Lung Cancer
Volume 45, Supplement , Pages S17-S20, August 2004

Malignant pleural mesothelioma in Turkey, 2000–2002

Department of Chest Diseases, School of Medicine, Hacettepe University Hospital, Sihhiye, Ankara 06100, Turkey

Abstract 

Both asbestos and erionite related malignant pleural mesothelioma (MPM) is a serious health problem in Turkey. Erionite has a higher potency in the lung than asbestos and familial clustering of malignant mesothelioma suggests a genetic predisposition to this cancer among affected individuals. Neither Simian virus 40 (SV40) nor human herpes virus 8 (HHV-8) are co-factors in the pathenogenesis of environmentally induced mesothelioma. A survival advantage has been demonstrated in patients with asbestos-induced mesothelioma compared with erionite-induced mesothelioma. This together with the proliferation index (PI) can be used as an independent prognostic factor for patients with malignant pleural mesothelioma. It is envisaged that the application of these prognostic approaches together with the new TNM staging system will allow investigations to be more precisely carried out and evaluated.

Keywords:  Asbestos, Erionite, Higher carcinogenic potency of erionite, Familial clustering, Survival advantage, Proliferation index

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0169-5002(04)00165-5

doi:10.1016/j.lungcan.2004.04.009

Lung Cancer
Volume 45, Supplement , Pages S17-S20, August 2004

Article Tools